These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 17918731

  • 1. Liposomal delivery of hydrophobic weak acids: enhancement of drug retention using a high intraliposomal pH.
    Joguparthi V, Anderson BD.
    J Pharm Sci; 2008 Jan; 97(1):433-54. PubMed ID: 17918731
    [Abstract] [Full Text] [Related]

  • 2. Liposome transport of hydrophobic drugs: gel phase lipid bilayer permeability and partitioning of the lactone form of a hydrophobic camptothecin, DB-67.
    Joguparthi V, Xiang TX, Anderson BD.
    J Pharm Sci; 2008 Jan; 97(1):400-20. PubMed ID: 17879989
    [Abstract] [Full Text] [Related]

  • 3. Determination of intraliposomal pH and its effect on membrane partitioning and passive loading of a hydrophobic camptothecin, DB-67.
    Joguparthi V, Feng S, Anderson BD.
    Int J Pharm; 2008 Mar 20; 352(1-2):17-28. PubMed ID: 18065174
    [Abstract] [Full Text] [Related]

  • 4. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions.
    Modi S, Xiang TX, Anderson BD.
    J Control Release; 2012 Sep 10; 162(2):330-9. PubMed ID: 22800581
    [Abstract] [Full Text] [Related]

  • 5. Influence of intravesicular pH drift and membrane binding on the liposomal release of a model amine-containing permeant.
    Tejwani RW, Anderson BD.
    J Pharm Sci; 2008 Jan 10; 97(1):381-99. PubMed ID: 17694543
    [Abstract] [Full Text] [Related]

  • 6. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
    Fugit KD, Anderson BD.
    J Control Release; 2014 Jan 28; 174():88-97. PubMed ID: 24231406
    [Abstract] [Full Text] [Related]

  • 7. Effect of cyclodextrin complexation on the liposome permeability of a model hydrophobic weak Acid.
    Joguparthi V, Anderson BD.
    Pharm Res; 2008 Nov 28; 25(11):2505-15. PubMed ID: 18642063
    [Abstract] [Full Text] [Related]

  • 8. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L, Cui F, Cun D, Tao A, Shi K, Lin W.
    Int J Pharm; 2007 Aug 01; 340(1-2):163-72. PubMed ID: 17482779
    [Abstract] [Full Text] [Related]

  • 9. Copper ion-mediated liposomal encapsulation of mitoxantrone: the role of anions in drug loading, retention and release.
    Li C, Cui J, Li Y, Wang C, Li Y, Zhang L, Zhang L, Guo W, Wang J, Zhang H, Hao Y, Wang Y.
    Eur J Pharm Sci; 2008 Aug 07; 34(4-5):333-44. PubMed ID: 18573336
    [Abstract] [Full Text] [Related]

  • 10. Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery.
    Lasic DD, Ceh B, Stuart MC, Guo L, Frederik PM, Barenholz Y.
    Biochim Biophys Acta; 1995 Nov 01; 1239(2):145-56. PubMed ID: 7488619
    [Abstract] [Full Text] [Related]

  • 11. The highly lipophilic DNA topoisomerase I inhibitor DB-67 displays elevated lactone levels in human blood and potent anticancer activity.
    Bom D, Curran DP, Zhang J, Zimmer SG, Bevins R, Kruszewski S, Howe JN, Bingcang A, Latus LJ, Burke TG.
    J Control Release; 2001 Jul 06; 74(1-3):325-33. PubMed ID: 11489514
    [Abstract] [Full Text] [Related]

  • 12. A versatile prodrug approach for liposomal core-loading of water-insoluble camptothecin anticancer drugs.
    Liu X, Lynn BC, Zhang J, Song L, Bom D, Du W, Curran DP, Burke TG.
    J Am Chem Soc; 2002 Jul 03; 124(26):7650-1. PubMed ID: 12083906
    [Abstract] [Full Text] [Related]

  • 13. Modified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulation.
    Shi K, Tian Y, Jiang Y, Wang L, Cui F.
    Pharm Dev Technol; 2010 Dec 03; 15(6):644-52. PubMed ID: 19943738
    [Abstract] [Full Text] [Related]

  • 14. The effects of pH and intraliposomal buffer strength on the rate of liposome content release and intracellular drug delivery.
    Lee RJ, Wang S, Turk MJ, Low PS.
    Biosci Rep; 1998 Apr 03; 18(2):69-78. PubMed ID: 9743475
    [Abstract] [Full Text] [Related]

  • 15. A targeted liposome delivery system for combretastatin A4: formulation optimization through drug loading and in vitro release studies.
    Nallamothu R, Wood GC, Kiani MF, Moore BM, Horton FP, Thoma LA.
    PDA J Pharm Sci Technol; 2006 Apr 03; 60(3):144-55. PubMed ID: 17089683
    [Abstract] [Full Text] [Related]

  • 16. Hexosomes formed from glycerate surfactants--formulation as a colloidal carrier for irinotecan.
    Boyd BJ, Whittaker DV, Khoo SM, Davey G.
    Int J Pharm; 2006 Aug 02; 318(1-2):154-62. PubMed ID: 16621358
    [Abstract] [Full Text] [Related]

  • 17. Determination of liposome partitioning of ionizable drugs by titration.
    Balon K, Riebesehl BU, Müller BW.
    J Pharm Sci; 1999 Aug 02; 88(8):802-6. PubMed ID: 10430546
    [Abstract] [Full Text] [Related]

  • 18. Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
    Ramsay E, Alnajim J, Anantha M, Taggar A, Thomas A, Edwards K, Karlsson G, Webb M, Bally M.
    Pharm Res; 2006 Dec 02; 23(12):2799-808. PubMed ID: 17063397
    [Abstract] [Full Text] [Related]

  • 19. pH-dependent association of SN-38 with lipid bilayers of a novel liposomal formulation.
    Peikov V, Ugwu S, Parmar M, Zhang A, Ahmad I.
    Int J Pharm; 2005 Aug 11; 299(1-2):92-9. PubMed ID: 15996839
    [Abstract] [Full Text] [Related]

  • 20. Novel camptothecin analogue (gimatecan)-containing liposomes prepared by the ethanol injection method.
    Stano P, Bufali S, Pisano C, Bucci F, Barbarino M, Santaniello M, Carminati P, Luisi PL.
    J Liposome Res; 2004 Aug 11; 14(1-2):87-109. PubMed ID: 15461935
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.